Previous studies have shown arctiin to have chemotherapeutic effects against cervical cancer by inhibiting the PI3K/AKT pathway; however, this study is the first to illustrate arctiin's anticancer effects on ESC [22]. This evidence concerns the gene AKT1 and cervical carcinoma.